We next used the LM22 signature matrix35, a validated gene signature matrix of 22 haematopoietic cell types, to compare the immune composition of the SCLC-transformed liver with the EGFR mutant samples in the TRACERx cohort. This evidence concerns the gene EGFR and small cell lung carcinoma.